1National Committee for Clinical Laboratory Standard, 2002. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS, Wayne, Pa.
2Rhomberg PR, Jones RN , MYSTIC Study Group. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials:report from the MYSTIC Program (2002) in North America. Diagn Microbiol Infect Dis, 2003,47:365-372.
3Pfaller MA, Jones RN , MYSTIC Study Group. Antimicrobial susceptibility of inducible Amp C β-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002,19:383-388.
4Sader HS, Biedenbach DJ ,Jones RN. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis, 2003,47:361-364.
5Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals:summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis, 2001,5:200-214.
2Ali SA, Tahir SM, Memon AS, et al. Pattern of pathogens and their sensitivity isolated from superficial surgical site infections in a tertiary care hospital[J]. J Ayub Med Coll Abbottabad,2009,21(2):80-82.
3Fehr J, Hatz C, Soka l,et al. Antimicrobial prophylaxis to prevent surgical site infections in a rural sub-Saharan hospital [J]. Clin Microbiol Infect, 2006,12(12) : 1224-1227.
4Saxer F, Widmer A, Fehr J, et al. Benefit of a single preoperative dose of antibiotics in a sub-saharan district hospital minimal input, massive impact[J]. Ann Surg,2009,249(2) :322- 326.
